Pancreatitis
Pancreatitis is an inflammation of the pancreas, an organ behind the stomach that produces digestive enzymes and hormones. It manifests predominantly as upper abdominal pain that may radiate to the back, along with symptoms like nausea, vomiting, diarrhea, a swollen or tender abdomen, fast heartbeat, and fever, and can occur in either acute or chronic forms.
Health Outcomes
- Accelerated Autoimmune Pancreatitis Progression
- Changed Bicarbonate Level
- Changed Clinical Chemistry Measure
- Changed Magnesium Level
- Changed Serum Calcium Level
- Elevated Lactate Levels
- Elevated sIgG4 Levels
- Enhanced Digestive Enzyme Activity
- Enhanced Digestive Process Survival
- Improved Abdominal Pain Severity
- Improved Bioavailability
- Improved Digestive Enzyme Activity
- Improved Enteral Nutrition Achievement Time
- Improved Enzyme Activity
- Improved Hepatopancreas Health
- Improved Lipase Activity
- Improved Nutrient Digestibility
- Improved Pancreatic Tissue Repair
- Improved Plasma Total Protein
- Improved Protein Digestion
- Improved Protein Utilization
- Increased Anion Gap
- Increased Cholecystokinin Level
- Increased Cytoprotection Against Tissue Damage
- Increased Emesis
- Increased Glucagon Level
- Increased Incidence of Abdominal Symptoms
- Increased Interleukin 8 Levels
- Increased Lipase Activity
- Increased Narcotic Consumption
- Increased Occurrence of Serious Adverse Events
- Increased Plasma Glucagon Level
- Increased Protein Digestibility
- Increased Sepsis Incidence
- Increased Serum Amylase Activity
- Increased Serum Lipase Levels
- Increased Total Acidity Levels
- Increased Triglyceride Level
- Increased β-glucosidase Levels
- Inhibited Digestive Enzyme Activity
- Inhibited α-Amylase Activity
- Maintained Blood Calcium Level
- Maintained pH Levels
- Multiorgan Failure
- Neutralized Reactive Oxygen Species
- Preserved Islets of Langerhans
- Prevention of Beta-Cell Loss
- Reduced Abdominal Dull Ache
- Reduced Abdominal Pain Intensity
- Reduced Acute Pancreatitis Severity
- Reduced Alcohol Consumption
- Reduced Amylase Level
- Reduced Apolipoprotein C-III Level
- Reduced C-Peptide Level
- Reduced Calcium Level
- Reduced Duration to Full Enteral Feeding
- Reduced Electrolyte Level
- Reduced Epigastric Discomfort
- Reduced Epigastric Pain
- Reduced Fasting Glucagon Level
- Reduced Gastric Emptying
- Reduced Glucagon Level
- Reduced Harmful Enzyme Activity
- Reduced Hypocalcemia
- Reduced Hypocalcemia Risk
- Reduced Incidence of Post-ERCP Pancreatitis
- Reduced Insulin Level
- Reduced Intra-Abdominal Infections
- Reduced Length of Hospitalization
- Reduced Life Threatening Complication
- Reduced Nausea Severity
- Reduced Nausea Symptom Severity
- Reduced Nausea and Vomiting
- Reduced Organ Dysfunction Severity
- Reduced Pancreatic Inflammation
- Reduced Pancreatic Inflammatory and Metabolic Dysregulation
- Reduced Phospholipid Level
- Reduced Post-ERCP Pancreatitis Severity
- Reduced Postprandial Insulin Response
- Reduced Pyloric Pressure
- Reduced Risk of Abdominal Surgery
- Reduced Time to Enteral Nutrition Transition
- Reduced Total Morphine Consumption
- Reduced Visceral Pain
- Reduced Vitamin A Level
- Reduced Vitamin E Level
- Worsened Dyspeptic Symptoms